Literature DB >> 21254896

Association of liver enzymes with metabolic syndrome and carotid atherosclerosis in young adults. The Cardiovascular Risk in Young Finns Study.

Juha Koskinen1, Costan G Magnussen, Mika Kähönen, Britt-Marie Loo, Jukka Marniemi, Antti Jula, Liisa A Saarikoski, Risto Huupponen, Jorma S A Viikari, Olli T Raitakari, Markus Juonala.   

Abstract

OBJECTIVE: We examined whether metabolic syndrome (MetS) predicts increased alanine aminotransferase (ALT) and gamma-glutamyltransferase (GGT) levels in young adults, whether spontaneous recovery from MetS has a favorable effect on liver enzyme activities, and whether these enzymes contribute to the atherogenicity of MetS (assessed by carotid intima-media thickness (IMT)).
METHODS: The study included 1,553 subjects (base-line age 31.5 ± 5.0 years). ALT and GGT were measured in 2007. MetS was diagnosed by the new Joint Interim Societies definition.
RESULTS: ALT and GGT levels were higher in subjects with MetS compared to those without in 2007. The association was independent of alcohol intake and BMI. In multivariable models adjusted for base-line age, LDL cholesterol, CRP, alcohol intake, and adiponectin, MetS in 2001 predicted increased ALT (β ± SEM = 0.320 ± 0.062, P < 0.0001 in men; 0.134 ± 0.059, P = 0.02 in women) and GGT (β ± SEM = 0.222 ± 0.067, P < 0.0001 in men; 0.236 ± 0.060, P < 0.0001 in women) levels after 6 years. Subjects with MetS only at base-line (2001) had lower ALT levels after 6 years compared to subjects with persistent and incident MetS. No statistically significant interaction for MetS*ALT (P = 0.81) or MetS*GGT (P = 0.92) on IMT was observed.
CONCLUSION: In young adults MetS may induce liver enzyme changes that indicate increased risk of non-alcoholic fatty liver disease, but we found no evidence that increased enzyme levels would amplify the atherogenicity of MetS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21254896     DOI: 10.3109/07853890.2010.532152

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  7 in total

Review 1.  Nonalcoholic fatty liver disease and cardiovascular disease.

Authors:  Hong Liu; Hong-Yun Lu
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

2.  Frequency of Nonalcoholic Fatty Liver Disease and Subclinical Atherosclerosis Among Young Mexican Americans.

Authors:  Clarence Gill; Kristina P Vatcheva; Jen-Jung Pan; Beverly Smulevitz; David D McPherson; Michael Fallon; Joseph B McCormick; Susan P Fisher-Hoch; Susan T Laing
Journal:  Am J Cardiol       Date:  2017-03-16       Impact factor: 2.778

Review 3.  Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Valerio Nobili; Anna Alisi; Kimberly P Newton; Jeffrey B Schwimmer
Journal:  Gastroenterology       Date:  2016-03-19       Impact factor: 22.682

Review 4.  Nonalcoholic Fatty Liver Disease in Children: Not a Small Matter.

Authors:  Praveen Kumar Conjeevaram Selvakumar; Mohammad Nasser Kabbany; Naim Alkhouri
Journal:  Paediatr Drugs       Date:  2018-08       Impact factor: 3.022

5.  Lack of a relationship between circulating gamma-glutamyltransferase levels and carotid intima media thickness in hypertensive and diabetic patients.

Authors:  Marco Nuti; Paolo Spontoni; Chrysanthos Grigoratos; Giulia Dell'Omo; Alberto Balbarini; Roberto Pedrinelli
Journal:  Vasc Health Risk Manag       Date:  2012-05-01

6.  Liver enzymes and metabolic syndrome: a large-scale case-control study.

Authors:  Lu Zhang; Xiangyu Ma; Zhi Jiang; Kejun Zhang; Mengxuan Zhang; Yafei Li; Xiaolan Zhao; Hongyan Xiong
Journal:  Oncotarget       Date:  2015-09-29

7.  Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old.

Authors:  Jilin Zheng; Yong Zhou; Kuo Zhang; Yu Qi; Shimin An; Siyuan Wang; Xingquan Zhao; Yi-Da Tang
Journal:  BMC Cardiovasc Disord       Date:  2018-07-16       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.